MENU
Go to the list of all blogs
Anna G's Avatar
published in Blogs
Apr 14, 2023

Expect Uptrend to Continue as Exact Sciences (EXAS, $67.02) Experiences Weekly Bullish Trend

The rise of AI in the stock market has brought about new possibilities for traders and investors to make informed decisions. For EXAS, Tickeron's Earnings Trader (TA) bot has been one of the best performers in their robot factory. This particular bot is accessible through their website, and traders can use it to gain insights into potential trading opportunities. The bot leverages AI and technical analysis to provide recommendations for buying and selling EXAS stock.


As a technical analyst, it is important to stay up to date with the latest trends and signals in the stock market. In this article, we will take a closer look at Exact Sciences Corp (EXAS, $67.02) and its recent performance.

According to A.I.dvisor, EXAS is expected to experience a growth of 2% to reach $68.36 or more in the coming week. The stock has been on a winning streak for a consecutive week, and the odds of an Uptrend continuation are currently at 77%.

However, investors should be cautious as EXAS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 05, 2023. This indicates a bearish signal and suggests that the stock may decline going forward. Tickeron's A.I.dvisor has analyzed 47 instances where the MACD turned negative, and in 42 of those cases, the stock moved lower in the days that followed. This puts the odds of a downward move for EXAS at 89%.

While it is always important to be mindful of potential risks, it is worth noting that past performance does not guarantee future results. As such, investors should continue to monitor the market closely and make informed decisions based on current trends and signals.
If you're interested in stocks and want to stay ahead of the game, consider registering with us, click here. Our platform utilizes the power of AI to provide you with valuable insights and analysis, helping you make informed decisions when it comes to trading and investing. Don't miss out on this opportunity to take your stock market game to the next level. Register with us now and start making money!

Related Ticker: EXAS

EXAS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for EXAS turned positive on October 01, 2025. Looking at past instances where EXAS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 30, 2025. You may want to consider a long position or call options on EXAS as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for EXAS moved above the 200-day moving average on October 14, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EXAS advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 196 cases where EXAS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXAS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EXAS broke above its upper Bollinger Band on October 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EXAS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.955) is normal, around the industry mean (12.590). P/E Ratio (0.000) is within average values for comparable stocks, (143.938). EXAS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.839). EXAS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (4.100) is also within normal values, averaging (10.102).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 12.17B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 40%. ANPCY experienced the highest price growth at 122%, while SLDX experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 66
Price Growth Rating: 52
SMR Rating: 81
Profit Risk Rating: 90
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EXAS showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of proprietary technologies for the detection of cancer

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5505 Endeavor Lane
Phone
+1 608 284-5700
Employees
6600
Web
https://www.exactsciences.com
Interact to see
Advertisement
Wall Street expects strong profit growth from the Magnificent Seven tech giants in 2025. Discover how to trade Apple, Microsoft, Amazon, Nvidia, Tesla, Meta, and Alphabet using AI-powered Double Agent strategies and smart hedging with inverse ETFs like QID.
On May 2, 2025, a diverse group of companies across energy, financial services, basic materials, consumer discretionary, and healthcare will release their Q1 2025 earnings.
In April 2025, five tech giants—NVIDIA, Tesla, Meta, Palantir, and Amazon—each surged over 40%, driven by AI breakthroughs, strong earnings, and market momentum. Discover what fueled the rally and how Tickeron’s AI trading bots helped investors outperform even these star stocks.
#investment
Markets ended April with mixed signals—gold slid on trade optimism, Big Tech lifted the Nasdaq, and Bitcoin steadied near $94K. With U.S. GDP contracting and job growth beating forecasts, investors brace for more volatility amid tariffs and central bank moves.
As Warren Buffett announces his retirement, investors turn to his trusted Buffett Indicator—a ratio of market cap to GDP—as a key gauge of market valuation.
#investment
Markets move in repeating cycles—Accumulation, Uptrend, Distribution, and Downtrend. Learn how to recognize each phase and deploy Tickeron’s AI-powered Double Agent strategy to adapt, protect capital, and profit in any market condition.
#trading
Discover how confirmation trading techniques—like moving average crossovers and volume-backed breakouts—can improve accuracy and reduce false signals. Learn how Tickeron’s AI automates these strategies for smarter, faster, and more disciplined trading.
#trading
Hedge funds are ramping up bearish bets on small-cap stocks, with Russell 2000 short interest hitting new highs. As macro headwinds mount and technical support teeters, Tickeron’s AI Double Agents step in to navigate the looming sell-off with precision.
#investment#trading#artificial_intelligence
SPY’s Momentum Indicator turned bullish on April 25, 2025, signaling a potential trend shift with a 90% historical success rate. This article explores how economic scarcity, technical signals, and AI-driven tools like Tickeron’s A.I.dvisor shape investor decisions in volatile markets.
#trading
On May 7, 2025, NVIDIA gained 3.1% on bullish AI momentum and strong data center demand, while Alphabet plunged over 7% amid regulatory fears and growing AI competition—highlighting the tech sector's diverging fortunes in a volatile market.
#investment
A volatile week in financial markets saw the S&P 500 pull back after a record streak, gold surge nearly 5% on Fed jitters, and Bitcoin soar past $104K on trade deal hopes—highlighting the growing impact of policy decisions, earnings, and geopolitical sentiment on asset prices.
ickeron’s AI-powered prediction that Bitcoin would reach $109,000 is nearing reality, as BTC climbs to $103,000. This article explores the accuracy of the forecast, the market forces behind the rally, and how traders can leverage AI tools like Double Agents to stay ahead.
#trading#investment
Monero (XMR) has flashed a bullish signal as its 10-day moving average crosses above the 50-day, historically marking the start of uptrends. With renewed focus on digital privacy and support from Tickeron’s AI agents, XMR may be poised for a quiet breakout.
Tech giants Microsoft, Oracle, Meta, Amazon, and Alphabet (MOMAA) are set to invest a record $320B in AI and cloud infrastructure in 2025—a bold move that could reshape the digital economy. This article explores what’s driving the surge and how investors can respond.
Tickeron’s AI has detected a Rectangle Bottom Bullish pattern in Starbucks (SBUX), signaling a potential short-term rally. With a breakout price of $84.77 and a 63% confidence level, traders are watching closely as AI-driven insights point to a possible upward trend.
#trading
Cisco Systems is set to release its Q3 2025 earnings on May 14, with analysts expecting $0.91 EPS and $14.05B in revenue. This report will test Cisco’s strength in AI and cybersecurity amid networking headwinds. Can Tickeron’s AI Double Agent predict the market reaction?
#investment
U.S. corporate earnings revisions have turned positive for the first time in 2025, signaling renewed analyst confidence. As major firms like Walmart and ExxonMobil report Q1 results, traders look to Tickeron’s AI tools for guidance in a shifting market landscape.
#trading#artificial_intelligence
Enhance your trading with a customizable watchlist that tracks top-performing stocks, ETFs, Forex, and crypto. Set AI-powered Buy/Sell alerts, automate trades with robots, and monitor key performance metrics—all from one streamlined dashboard.
#trading
Bank of America Corporation (NYSE: BAC) remains a cornerstone of the U.S. financial sector, with its vast operations and significant market presence.
#artificial_intelligence#trading